Literature DB >> 17616174

S-adenosyl-L-methionine-dependent methyl transfer: observable precatalytic intermediates during DNA cytosine methylation.

Ben Youngblood1, Fa-Kuen Shieh, Fabian Buller, Tim Bullock, Norbert O Reich.   

Abstract

S-adenosyl-L-methionine- (AdoMet-) dependent methyltransferases are widespread, play critical roles in diverse biological pathways, and are antibiotic and cancer drug targets. Presently missing from our understanding of any AdoMet-dependent methyl-transfer reaction is a high-resolution structure of a precatalytic enzyme/AdoMet/DNA complex. The catalytic mechanism of DNA cytosine methylation was studied by structurally and functionally characterizing several active site mutants of the bacterial enzyme M.HhaI. The 2.64 A resolution protein/DNA/AdoMet structure of the inactive C81A M.HhaI mutant suggests that active site water, an approximately 13 degree tilt of the target base toward the active site nucleophile, and the presence or absence of the cofactor methylsulfonium are coupled via a hydrogen-bonding network involving Tyr167. The active site in the mutant complex is assembled to optimally align the pyrimidine for nucleophilic attack and subsequent methyl transfer, consistent with previous molecular dynamics ab initio and quantum mechanics/molecular mechanics calculations. The mutant/DNA/AdoHcy structure (2.88 A resolution) provides a direct comparison to the postcatalytic complex. A third C81A ternary structure (2.22 A resolution) reveals hydrolysis of AdoMet to adenosine in the active site, further validating the coupling between the methionine portion of AdoMet and ultimately validating the structural observation of a prechemistry/postchemistry water network. Disruption of this hydrogen-bonding network by a Tyr167 to Phe167 mutation does not alter the kinetics of nucleophilic attack or methyl transfer. However, the Y167F mutant shows detectable changes in kcat, caused by the perturbed kinetics of AdoHcy release. These results provide a basis for including an extensive hydrogen-bonding network in controlling the rate-limiting product release steps during cytosine methylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616174     DOI: 10.1021/bi7005948

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthesis.

Authors:  Yingying Wu; Qianjin Kang; Guangdong Shang; Peter Spiteller; Brian Carroll; Tin-Wein Yu; Wenjin Su; Linquan Bai; Heinz G Floss
Journal:  Chembiochem       Date:  2011-06-16       Impact factor: 3.164

2.  5-Methylation of cytosine in CG:CG base-pair steps: a physicochemical mechanism for the epigenetic control of DNA nanomechanics.

Authors:  Tahir I Yusufaly; Yun Li; Wilma K Olson
Journal:  J Phys Chem B       Date:  2013-12-16       Impact factor: 2.991

Review 3.  Molecular and enzymatic profiles of mammalian DNA methyltransferases: structures and targets for drugs.

Authors:  F Xu; C Mao; Y Ding; C Rui; L Wu; A Shi; H Zhang; L Zhang; Z Xu
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

4.  Introduction--Epiphanies in epigenetics.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  Identification of novel inhibitors of S-adenosyl-L-homocysteine hydrolase via structure-based virtual screening and molecular dynamics simulations.

Authors:  Cong Chen; Xiang-Hui Zhou; Wa Cheng; Yan-Fen Peng; Qi-Ming Yu; Xiang-Duan Tan
Journal:  J Mol Model       Date:  2022-09-30       Impact factor: 2.172

6.  DNA cytosine methylation: structural and thermodynamic characterization of the epigenetic marking mechanism.

Authors:  Jin Yang; Lee Lior-Hoffmann; Shenglong Wang; Yingkai Zhang; Suse Broyde
Journal:  Biochemistry       Date:  2013-04-12       Impact factor: 3.162

Review 7.  Mammalian DNA methyltransferases: a structural perspective.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Structure       Date:  2008-03       Impact factor: 5.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.